8-K
filed October 28, 2022, 7:59 PM ET
ticker ANEB
CIK 0001815974
other
confidence high
sentiment neutral
materiality 0.15
Anebulo shareholders elect three Class II directors, ratify auditor at 2022 annual meeting
Anebulo Pharmaceuticals, Inc.
- Directors elected: Nat Calloway (15,985,642 for, 7,456 withheld), Areta Kupchyk (15,982,304 for, 10,794 withheld), Kenneth Lin (15,982,304 for, 10,794 withheld).
- Ratification of EisnerAmper LLP as independent auditor for FY2023 approved: 15,992,762 for, 335 against, 1 abstention.
- No broker non-votes on director elections; broker discretionary voting allowed on auditor ratification.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Anebulo Pharmaceuticals, Inc. shareholders approved Ratification of the selection by the Audit Committee of the Board of Directors of EisnerAmper LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2023. at the 2022-10-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-10-28
Exact text from the filing
The voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 15,992,762 335 1 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Anebulo Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2022-10-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-10-28
Exact text from the filing
Name Votes For Withheld Broker Non-Votes Nat Calloway 15,985,642 7,456 0 Areta Kupchyk 15,982,304 10,794 0 Kenneth Lin 15,982,304 10,794 0
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.